menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats

17 5
31.07.2025
The U.S. is a key market for the pharmaceutical industry. AstraZeneca expects 50 percent of its revenue to come from the U.S. by 2030.

© Fortune